Clinical efficacy of deprenyl, a specific inhibitor of MAOB.
D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000328:Adult; D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000523:psychology; D004311:Double-Blind Method; D006801:Humans; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D019964:Mood Disorders / Q000188:drug therapy* / Q000378:metabolism; D010627:Phenethylamines / Q000627:therapeutic use*; D010903:Pituitary Gland, Anterior / Q000378:metabolism; D011976:Receptors, Muscarinic / Q000187:drug effects; D012642:Selegiline / Q000627:therapeutic use*; D014439:Tyramine / Q000494:pharmacology
D008996:Monoamine Oxidase Inhibitors; D010627:Phenethylamines; D011976:Receptors, Muscarinic; D012642:Selegiline; D000324:Adrenocorticotropic Hormone; D014439:Tyramine